Moreover, Gal3 knockout was demonstrated to reduce the plaque burden and improve cognitive behaviors in 2 transgenic mouse models of AD (APP/PS1 and 5xFAD) (1, 19). The gene discussed is APP; the disease is Alzheimer disease.